Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader ...
Jan 25 (Reuters) - Medical device company NuVasive Inc. said it acquired bone grafting technology from privately held, California-based Radius Medical LLC for about $16 million in cash and stock. The ...
AUDUBON, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of NuVasive Specialized ...
NuVasive, Inc. NUVA recently announced the receipt of the FDA 510(k) approval for expanded indications of use for Attrax Putty, with its wide-ranging thoracolumbar interbody portfolio for spine ...
NuVasive, Inc. NUVA recently made a significant advancement in the high-potential surgical spine procedures space. The company launched the Cohere TLIF-O implant and also revealed its plans to launch ...
A recent review is transforming the landscape of craniomaxillofacial bone regeneration with the introduction of personalized bioceramic grafts. This pioneering research explores the fabrication and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback